-
公开(公告)号:US11629189B2
公开(公告)日:2023-04-18
申请号:US16955219
申请日:2018-12-19
申请人: KYMAB LIMITED
发明人: Matthew John McCourt , Richard Charles Alfred Sainson , Jamie Iain Campbell , Stephen John Arkinstall , Mihriban Tuna , Ryan Fiehler , Mustapha Faroudi , Fadi Badr , Francisca Wollerton Van Horck , Frederick Akele
摘要: Multispecific antibody in mAb2 format, comprising an ICOS-binding Fab region and a PD-L1-binding Fcab region. Use of the multispecific antibody in immuno-oncology, including for treatment of solid tumours. Combination therapy including antibody to another immune checkpoint molecule such as PD-1 and CTLA-4, in addition to anti-ICOS and anti-PD-L1.